Filter
1250
Text search:
pharmaceutical
situation
Featured
Recommendations
118
New Publications
329
Language
Document type
No document type
627
Studies & Reports
249
Guidelines
199
Strategic & Response Plan
64
Manuals
55
Fact sheets
17
Training Material
15
Situation Updates
14
Resource Platforms
5
Infographics
4
Brochures
1
Countries / Regions
Ethiopia
57
Kenya
53
India
46
South Africa
36
Global
36
Nigeria
34
Western and Central Europe
34
Sierra Leone
31
Uganda
31
Liberia
25
Ghana
25
Tanzania
22
Namibia
19
Ukraine
19
Malawi
18
Zambia
15
Rwanda
15
Latin America and the Carribbean
15
Nepal
14
Syria
14
Eastern Europe
14
Philippines
13
Africa
13
Indonesia
12
Bangladesh
12
Zimbabwe
11
Cambodia
11
Congo, Democratic Republic of
10
Lesotho
9
Myanmar / Burma
9
South–East Asia Region
9
Germany
8
Cameroon
7
Thailand
6
Botswana
6
West and Central Africa
6
Asia
6
Venezuela
6
Vietnam
6
South Sudan
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Albania
5
Burkina Faso
4
Senegal
4
Haiti
4
China
4
Papua New Guinea
4
Laos
4
Guinea
3
Mali
3
Pakistan
3
Jordan
3
Egypt
3
Mozambique
3
Benin
3
Middle East and North Africa
3
Western Pacific Region
3
Fiji
3
Iraq
2
Sudan
2
Central African Republic
2
Brazil
2
North Macedonia
2
Chile
2
East and Southern Africa
2
Lithuania
2
Moldova
2
Jamaica
2
USA
1
Niger
1
Somalia
1
Afghanistan
1
Lebanon
1
Chad
1
Ireland
1
Peru
1
Serbia
1
El Salvador
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Bulgaria
1
Romania
1
Iran
1
Kyrgyzstan
1
Georgia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
558
Key Resources
70
Clinical Guidelines
64
Public Health
47
Women & Child Health
27
Pharmacy & Technologies
17
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
143
COVID-19
125
Pharmacy
96
Mental Health
73
TB
52
HIV
42
Rapid Response
29
Conflict
28
NTDs
28
Planetary Health
25
Ebola & Marburg
24
Global Health Education
23
Caregiver
22
NCDs
20
Malaria
16
Health Financing Toolbox
15
2.0 Rapid Response
11
Disability
7
Polio
7
Refugee
7
Natural Hazards
6
Specific Hazards
6
Zika
4
Cholera
2
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, res
...
Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant
...
International Journal of Infectious Diseases 32 (2015) 111–117
This document introduces four strategic objectives and twelve operational principles for good pharmaceutical procurement. These objectives and principles have been developed and endorsed by the Interagency
...
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the ep
...
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
(Last Update: July 2022)
An update from the EU Early Warning System
In 2022, Namibia had an estimated population of 2.6 million people, where 51 per cent per cent are females and 52.5 per cent of households in urban areas, with fast-growing urban informal settlements which lack access to basic services. Namibia has a young population; 42 per cent are children (0-17
...
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys
...